Development Level

Tchem 4 | 1,890
Tbio 3 | 10,625

Disease

Cancer 5 | 2,346
psoriasis 4 | 6,685
Heart disease 3 | 279
Kidney disease 3 | 396
Rheumatoid Arthritis 3 | 1,160
Severe Combined Immunodeficiency 3 | 46
diabetes mellitus 3 | 1,663
glioblastoma 3 | 5,572
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
Anemia 2 | 252
Asthma 2 | 349
Hypersensitivity reaction type II disease 2 | 235
Lung disease 2 | 132
Lymphatic system disease 2 | 14
Neoplastic Cell Transformation 2 | 81
Thrombocytopenia 2 | 105
Vascular disease 2 | 281
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
medulloblastoma, large-cell 2 | 6,234
spina bifida 2 | 1,064
tuberculosis 2 | 1,557
Acquired immunodeficiency syndrome 1 | 164
Adult T-Cell Lymphoma/Leukemia 1 | 30
Agammaglobulinemia 1 | 24
Alopecia areata 1 | 37
Amnesia 1 | 17
Anorexia 1 | 15
Arthritis, Experimental 1 | 39
Brain Neoplasms 1 | 23
Brain disease 1 | 83
Breast fibroadenoma 1 | 8
Cannabis abuse 1 | 6
Capillary hemangioma 1 | 11
Cavernous hemangioma 1 | 12
Celiac disease 1 | 112
Colitis 1 | 46
Common variable immunodeficiency 1 | 72
Connective tissue disease 1 | 59
Cutaneous fibrous histiocytoma 1 | 16
Diarrhea 1 | 155
Encephalitis 1 | 54
Epidermodysplasia verruciformis 1 | 21
Exanthem 1 | 39
Fatty liver disease 1 | 84
Gastrointestinal system disease 1 | 50
Glomerulonephritis 1 | 36
HIV Infections 1 | 100
Hemangioma 1 | 35
Hepatitis 1 | 61
Hepatitis C 1 | 90
Herpes simplex 1 | 19
Human immunodeficiency virus infectious disease 1 | 92
Hyperactive behavior 1 | 31
Hyperglycemia 1 | 120
Hypotension 1 | 53
Infectious mononucleosis 1 | 15
Influenza 1 | 142
Kidney Neoplasm 1 | 27
Leber congenital amaurosis 1 | 72
Leiomyoma 1 | 25
Leprosy 1 | 77
Leukopenia 1 | 42
Li-Fraumeni Syndrome 1 | 13
Lipoma 1 | 19
Liver Cirrhosis 1 | 101
Liver Failure, Acute 1 | 22
Liver disease 1 | 219
Liver neoplasms 1 | 109
Lung Neoplasms 1 | 171
Lymphangioma 1 | 7
Lymphopenia 1 | 35
Measles 1 | 20
Melanoma 1 | 261
Myoepithelioma 1 | 12
Neoplasm Metastasis 1 | 138
Neoplasms, Experimental 1 | 33
Neurilemmoma 1 | 20
Neutropenia 1 | 78
Non-alcoholic Fatty Liver Disease 1 | 40
Osteoporosis 1 | 257
Pain 1 | 70
Polycythemia Vera 1 | 24
Precancerous Conditions 1 | 69
Schistosomiasis 1 | 38
Skin disease 1 | 65
Spinal cord disease 1 | 22
T cell deficiency 1 | 7
Tetanus 1 | 66
Thalassemia 1 | 46
Toxic shock syndrome 1 | 28
Toxoplasmosis 1 | 16
Tropical spastic paraparesis 1 | 17
Type 1 diabetes mellitus 1 | 101
Uveitis 1 | 103
Vaccinia 1 | 37
Wiskott-Aldrich syndrome 1 | 27
sarcoidosis 1 | 358

Tissue

Blood and immune system 7 | 17,995
Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Male tissues 7 | 17,969
Nervous System 7 | 18,561
Urinary Tract 7 | 18,444
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Liver and Pancreas 6 | 18,136
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115

Target Family

Non-IDG 4 | 11,971
Enzyme 1 | 4,146
Epigenetic 1 | 242
Kinase 1 | 634

Grant Application

1R21AI079769-01 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Growth factor receptor-bound protein 2 GRB2 Tchem Non-IDG -2.99303 933.5 424
Volume-regulated anion channel subunit LRRC8A LRRC8A Tbio Non-IDG -1.35971 30.0 111
Hematopoietic progenitor cell antigen CD34 CD34 Tbio Non-IDG -4.11691 13305.6 1625
V(D)J recombination-activating protein 2 RAG2 Tbio Epigenetic -2.88477 764.3 183
Interleukin-2 IL2 Tchem Non-IDG -4.34342 23652.7 1173
Mitogen-activated protein kinase 8 MAPK8 Tchem Kinase -3.75582 5333.9 1016
Activator of 90 kDa heat shock protein ATPase homolog 1 AHSA1 Tchem Enzyme -1.72375 45.9 513